The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures

Eur J Pharmacol. 1991 Jan 3;192(1):197-8. doi: 10.1016/0014-2999(91)90092-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / analogs & derivatives*
  • 2-Amino-5-phosphonovalerate / pharmacology
  • Animals
  • Diet
  • Dizocilpine Maleate / metabolism
  • Ethanol / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Seizures / prevention & control
  • Substance Withdrawal Syndrome / prevention & control*

Substances

  • Receptors, N-Methyl-D-Aspartate
  • CGP 39551
  • Ethanol
  • Dizocilpine Maleate
  • 2-Amino-5-phosphonovalerate